Heterocyclic modulators of lipid synthesis
US-2024400552-A1 · Dec 5, 2024 · US
US10944059B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10944059-B2 |
| Application number | US-201716336964-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 30, 2017 |
| Priority date | Oct 12, 2016 |
| Publication date | Mar 9, 2021 |
| Grant date | Mar 9, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a compound represented by Chemical Formula 1 for an organic optoelectronic device, an organic optoelectronic device employing the same and a display device. The details for Chemical Formula 1 above are as defined in the specification.
Opening claim text (preview).
The invention claimed is: 1. A compound for an organic optoelectronic device represented by Chemical Formula 1: wherein, in Chemical Formula 1, X is O or S, R 1 to R 5 are independently hydrogen, deuterium, a substituted or unsubstituted C1 to C5 alkyl group, or a substituted or unsubstituted C6 to C18 aryl group, L 1 and L 2 are independently a single bond, a substituted or unsubstituted C6 to C20 arylene group, or a substituted or unsubstituted C2 to C30 heteroarylene group, A 1 and A 2 are independently hydrogen, deuterium, a substituted or unsubstituted C6 to C18 aryl group, or a substituted or unsubstituted C2 to C30 heterocyclic group, and at least one of A 1 and A 2 comprises a moiety represented by Chemical Formula A, wherein, in Chemical Formula A, Z 1 to Z 5 are independently N or CR a , at least one of Z 1 to Z 5 is N, R a is independently hydrogen, deuterium, a substituted or unsubstituted C1 to C5 alkyl group, or a substituted or unsubstituted C6 to C18 aryl group, R a is independently present or adjacent groups thereof are linked with each other to form a substituted or unsubstituted aliphatic, aromatic or heteroaromatic monocyclic or polycyclic ring, and * is a linking point with L 1 or L 2 of Chemical Formula 1, wherein “substituted” refers to replacement of at least one hydrogen by deuterium, a cyano group, a C1 to C20 alkyl group, a C6 to C30 aryl group, or a C2 to C30 heteroaryl group. 2. The compound for an organic optoelectronic device of claim 1 , wherein Chemical Formula A is represented by one of Chemical Formula A1, Chemical Formula A2, Chemical Formula A3, and Chemical Formula A4: wherein, in Chemical Formula A1 to Chemical Formula A4, Z 1 , Z 3 , Z 5 , and Z 6 to Z 15 are independently N or CR a , at least one of Z 1 , Z 3 , Z 5 , and Z 6 to Z 15 of Chemical Formula A1 is N, at least one of Z 1 and Z 5 of Chemical Formulae A2 to A4 is N, m and n are independently one of integers of 0 to 2, R a to R e are independently hydrogen, deuterium, a substituted or unsubstituted C1 to C5 alkyl group, or a substituted or unsubstituted C6 to C18 aryl group, and * is a linking point with L 1 or L 2 of Chemical Formula 1. 3. The compound for an organic optoelectronic device of claim 1 , wherein A 1 and A 2 are independently hydrogen, deuterium, a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted pyridinyl group, a substituted or unsubstituted pyrimidinyl group, a substituted or unsubstituted triazinyl group, a substituted or unsubstituted quinolinyl group, a substituted or unsubstituted isoquinolinyl group, a substituted or unsubstituted quinazolinyl group, a substituted or unsubstituted benzoquinolinyl group, a substituted or unsubstituted benzoisoquinolinyl group, or a substituted or unsubstituted benzoquinazolinyl group, and at least one of A 1 and A 2 is a substituted or unsubstituted pyridinyl group, a substituted or unsubstituted pyrimidinyl group, a substituted or unsubstituted triazinyl group, a substituted or unsubstituted quinolinyl group, a substituted or unsubstituted isoquinolinyl group, a substituted or unsubstituted quinazolinyl group, a substituted or unsubstituted benzoquinolinyl group, a substituted or unsubstituted benzoisoquinolinyl group, or a substituted or unsubstituted benzoquinazolinyl group. 4. The compound for an organic optoelectronic device of claim 1 , wherein Chemical Formula A is selected from substituents of Group I: wherein, in Group I, * is a linking point with L 1 or L 2 of Chemical Formula 1. 5. The compound for an organic optoelectronic device of claim 1 , which is represented by one of Chemical Formula 1-A1-a1, Chemical Formula 1-A1-a2, Chemical Formula 1-A1-b1, Chemical Formula 1-A1-b2, Chemical Formula 1-A2-a, Chemical Formula 1-A2-b, Chemical Formula 1-A3-a, Chemical Formula 1-A3-b, Chemical Formula 1-A4-a, and Chemical Formula 1-A4-b: wherein, in Chemical Formula 1-A1-a1, Chemical Formula 1-A1-a2, Chemical Formula 1-A1-b1, Chemical Formula 1-A1-b2, Chemical Formula 1-A2-a, Chemical Formula 1-A2-b, Chemical Formula 1-A3-a, Chemical Formula 1-A3-b, Chemical Formula 1-A4-a and Chemical Formula 1-A4-b, X is O or S, R 1 to R 5 , R a , R a1 to R a4 , R b , R c , R d , and R e are independently hydrogen, deuterium, a substituted or unsubstituted C1 to C5 alkyl group, or a substituted or unsubstituted C6 to C12 aryl group, L 1 and L 2 are independently a single bond, or a substituted or unsubstituted C6 to C12 arylene group, and m and n are independently one of integers of 0 to 2. 6. The compound for an organic optoelectronic device of claim 1 , which is selected from compounds of Group 1:
comprising only nitrogen as heteroatom (H10K85/652 takes precedence) · CPC title
directly linked by a ring-member-to-ring-member bond · CPC title
containing three or more hetero rings · CPC title
ortho- or peri-condensed with carbocyclic rings or ring systems · CPC title
directly linked by a ring-member-to-ring-member bond · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.